Site searchBrightPath's neoantigen vaccine research published in Cancer Science
BrightPath and National Cancer Center, collaborator of the development of personalized neoantigen vaccine, published the research data to evaluate prediction accuracy of antigen-prediction algorithm commnly used in BP1101 and BP1209 in Cancer Science.
Development of antigen-prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse
Charneau et al. Cancer Science 2022
https://onlinelibrary.wiley.com/doi/10.1111/cas.15291